Evropská unie - islandština - EMA (European Medicines Agency)

mylan pharmaceuticals limited - meðferð með eviplera nýrnastarfsemi disoproxil maleat - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - treatment of hiv-1 infection:emtricitabine/tenofovir disoproxil mylan is indicated in antiretroviral combination therapy for the treatment of hiv-1 infected adults (see section 5. emtricitabine/tenofovir disoproxil mylan is also indicated for the treatment of hiv-1 infected adolescents, with nrti resistance or toxicities precluding the use of first line agents, (see sections 4. 2, 4. 4 og 5. pre-exposure prophylaxis (prep):emtricitabine/tenofovir disoproxil mylan is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired hiv-1 infection in adults and adolescents at high risk (see sections 4. 2, 4. 4 og 5.

Island - islandština - LYFJASTOFNUN (Icelandic Medicines Agency)

upjohn eesv - atorvastatin calcium - filmuhúðuð tafla - 80 mg

Island - islandština - LYFJASTOFNUN (Icelandic Medicines Agency)

upjohn eesv - atorvastatin calcium - filmuhúðuð tafla - 40 mg

Island - islandština - LYFJASTOFNUN (Icelandic Medicines Agency)

upjohn eesv - atorvastatin calcium - filmuhúðuð tafla - 20 mg

Island - islandština - LYFJASTOFNUN (Icelandic Medicines Agency)

upjohn eesv - atorvastatin calcium - filmuhúðuð tafla - 10 mg

Island - islandština - LYFJASTOFNUN (Icelandic Medicines Agency)

evolan pharma ab - midodrinum hýdróklóríð - tafla - 2,5 mg

Island - islandština - LYFJASTOFNUN (Icelandic Medicines Agency)

evolan pharma ab - midodrinum hýdróklóríð - tafla - 5 mg

Island - islandština - LYFJASTOFNUN (Icelandic Medicines Agency)

upjohn eesv - amlodipinum besýlat - tafla - 10 mg

Island - islandština - LYFJASTOFNUN (Icelandic Medicines Agency)

upjohn eesv - amlodipinum besýlat - tafla - 5 mg

Evropská unie - islandština - EMA (European Medicines Agency)

orion corporation - algengari ddc hemli, ef - parkinsonsveiki - taugakerfi - algengari/ddc hemli/upplýsingar Úr er ætlað fyrir meðferð fullorðinn sjúklinga með parkinsonsveiki og enda-af-skammt mótor sveiflur ekki á stöðugleika á algengari / dópa-dekarboxýlasa (ddc)-hemil meðferð.